Archive photo: FDA Buildings 1 and 21 at the White Oak campus in Silver Spring, Maryland, May 20, 2009. U.S. Food and Drug Administration / Public domain; cropped. Not from the October 2026 authorization announcement.
The Food and Drug Administration authorized the marketing of 24 Velo nicotine pouch products on October 30, expanding the list of pouches that may legally be sold in the United States while warning that authorization does not mean the products are safe.
The products are made by Modoral Brands Inc. and each is listed as containing 4 milligrams of nicotine. The decision brings the total number of FDA-authorized nicotine pouch products to 67, according to the agency.
The FDA’s current authorized-product list cautions that the products are not “FDA approved.” All tobacco products are harmful and potentially addictive, it says, and people who do not use tobacco should not start.
Why eight product names count as 24 authorizations
The latest decision covers eight product names across three types of packaging, rather than 24 distinct flavors. The Velo Mini Pouch and Velo Mini Pouch 2 lines each include four flavor varieties. All three packaging types incorporate certified child-resistant packaging.
Packaging matters in the agency’s review because it can affect stability, shelf life, moisture and safety. The FDA has previously urged manufacturers to use child-resistant packaging or other measures to reduce the risk of accidental nicotine poisoning in young children.
The products were reviewed through the premarket tobacco product application pathway under the FDA’s nicotine pouch pilot program. In its October 30 announcement, the agency said the pilot had shortened response times and made scientific reviews more efficient.
A population-level decision, not a safety endorsement
Before granting marketing authorization for a new tobacco product, the FDA considers risks and benefits for the population as a whole. That includes whether adults 21 and older who already use tobacco might benefit by switching completely to a potentially lower-risk product, weighed against risks to young people and non-users.
The agency said its evaluation found lower levels of harmful and potentially harmful constituents in the newly authorized products than in cigarettes and smokeless tobacco. Several carcinogenic constituents, including some linked to oral cancer risk among smokeless-tobacco users, were not measurable in the new products, it said.
That finding is not a declaration that the pouches are harmless, and the marketing decision is not approval of a medicine to help people stop smoking. The FDA stressed that adults seeking a health benefit from switching away from cigarettes or smokeless tobacco must switch completely; using both does not provide the same degree of benefit.
The authorizations apply to the specific products and packaging reviewed by the agency. They do not cover every product sold under the Velo brand.
JBizNews Health and Business Desk | Washington
© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.
.jpg){kind=link}